Medtronic plc — Director's Dealing 2016

Aug 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-08-01

Reporting Person: Kuntz Richard (SrVP & Chief Scien, Clin, Reg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-01	Ordinary Shares	A	9842	—	Acquired	118801	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-01	Stock Option (Right to Buy)	$88.06	A	39368	Acquired	2026-08-01	Ordinary Shares (39368)	Direct
2016-08-01	Stock Option (Right to Buy)	$88.06	A	1136	Acquired	2026-08-01	Ordinary Shares (1136)	Direct

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2019 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.